| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2970334 | The Journal of Heart and Lung Transplantation | 2014 | 7 Pages |
Abstract
Endothelin receptor antagonism reduces serum uric acid in PAH patients, and this reduction is associated with improved survival and longer TtCW. Further prospective studies are needed to investigate the pathogenic role of serum uric acid in PAH and its prognostic potential.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Neeraj MD, Jean-Luc MD, Raymond L. MD, Robert MD, Lie-Ju PhD, Xuexuan MS, Simon BSc, David J. MD, FRCP,